PFS and OS post-CAR-T according to BT modality and response. (A) PFS: comparing BT groups 1-year rates; no BT 46.0% (29.7-60.9), steroids 23.7% (10.2-40.2), RT 59.1% (44.8-70.9), CT 31.3% (23.9-38.9), CMT 45.5% (16.7-70.7). (B) OS: comparing BT groups 1-year rates; no BT 69.7% (51.4-82.2), steroids 37.4% (20.2-54.5), RT 70.3% (55.4-81.0), CT 46.9% (38.1-55.2), CMT 62.3% (27.8-84.0). (C) PFS: comparing BT responder vs nonresponder: HR 0.55 (0.39-0.79), P = .001. 1-year rates: Responder: 50.1% (39.6-59.7); Nonresponder: 29.7% (21.3-38.6). (D) OS: comparing BT responder vs nonresponder: HR 0.51 (0.33-0.77), P = .001. 1-year rates: Responder: 63.2% (51.5-72.8); Nonresponder: 45.9% (35.9-55.3).